149 related articles for article (PubMed ID: 24649108)
1. Single-nucleotide polymorphisms and copy number variations of the
Moriya H; Saito K; Helsby N; Hayashi N; Sugino S; Yamakage M; Sawaguchi T; Takasaki M; Takahashi M; Kurosawa N
Biomed Rep; 2014 Mar; 2(2):265-269. PubMed ID: 24649108
[TBL] [Abstract][Full Text] [Related]
2. Influence of the
Márquez Pete N; Maldonado Montoro MDM; Pérez Ramírez C; Martínez Martínez F; Martínez de la Plata JE; Daddaoua A; Jiménez Morales A
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207385
[TBL] [Abstract][Full Text] [Related]
3. Associations between FCGR2A rs1801274, FCGR3A rs396991, FCGR3B NA1/NA2 polymorphisms and periodontitis: a meta-analysis.
Song GG; Lee YH
Mol Biol Rep; 2013 Aug; 40(8):4985-93. PubMed ID: 23649770
[TBL] [Abstract][Full Text] [Related]
4. FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome.
Rossi GM; Bonatti F; Adorni A; Alberici F; Bodria M; Bonanni A; Ghiggeri GM; Martorana D; Vaglio A
Immunol Lett; 2018 Jan; 193():11-13. PubMed ID: 29155175
[TBL] [Abstract][Full Text] [Related]
5. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
Front Immunol; 2019; 10():1208. PubMed ID: 31249568
[TBL] [Abstract][Full Text] [Related]
6. Association between the functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta-analysis.
Lee YH; Song GG
Int J Rheum Dis; 2023 Jul; 26(7):1295-1304. PubMed ID: 37114884
[TBL] [Abstract][Full Text] [Related]
7. Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population.
Sadki K; Lamsyah H; Rueda B; Akil E; Sadak A; Martin J; El Aouad R
J Genet Genomics; 2010 Apr; 37(4):257-64. PubMed ID: 20439102
[TBL] [Abstract][Full Text] [Related]
8. Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis.
Lee YH; Song GG
Pharmacogenomics J; 2023 Nov; 23(6):210-216. PubMed ID: 37149714
[TBL] [Abstract][Full Text] [Related]
9. FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.
Ghesquières H; Larrabee BR; Haioun C; Link BK; Verney A; Slager SL; Ketterer N; Ansell SM; Delarue R; Maurer MJ; Fitoussi O; Habermann TM; Peyrade F; Dogan A; Molina TJ; Novak AJ; Tilly H; Cerhan JR; Salles G
Hematol Oncol; 2017 Dec; 35(4):447-455. PubMed ID: 27282998
[TBL] [Abstract][Full Text] [Related]
10. Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis.
Asano K; Matsumoto T; Umeno J; Hirano A; Esaki M; Hosono N; Matsui T; Kiyohara Y; Nakamura Y; Kubo M; Kitazono T
Inflamm Bowel Dis; 2013 Sep; 19(10):2061-8. PubMed ID: 23917248
[TBL] [Abstract][Full Text] [Related]
11. No association of primary Sjögren's syndrome with Fcγ receptor gene variants.
Haldorsen K; Appel S; Le Hellard S; Bruland O; Brun JG; Omdal R; Kristjansdottir G; Theander E; Fernandes CP; Kvarnström M; Eriksson P; Rönnblom L; Herlenius MW; Nordmark G; Jonsson R; Bolstad AI
Genes Immun; 2013 Jun; 14(4):234-7. PubMed ID: 23552400
[TBL] [Abstract][Full Text] [Related]
12. FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis.
Jiménez Morales A; Maldonado-Montoro M; Martínez de la Plata JE; Pérez Ramírez C; Daddaoua A; Alarcón Payer C; Expósito Ruiz M; García Collado C
J Clin Pharmacol; 2019 Apr; 59(4):517-531. PubMed ID: 30457672
[TBL] [Abstract][Full Text] [Related]
13. The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients.
López-Martínez R; Albaiceta GM; Amado-Rodríguez L; Cuesta-Llavona E; Gómez J; García-Clemente M; Vázquez-Coto D; Alvarez V; Coto E
Clin Immunol; 2022 Mar; 236():108954. PubMed ID: 35149195
[TBL] [Abstract][Full Text] [Related]
14. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.
Breunis WB; van Mirre E; Geissler J; Laddach N; Wolbink G; van der Schoot E; de Haas M; de Boer M; Roos D; Kuijpers TW
Hum Mutat; 2009 May; 30(5):E640-50. PubMed ID: 19309690
[TBL] [Abstract][Full Text] [Related]
15. FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-α blockers in psoriatic arthritis: a longitudinal study with 6 months of followup.
Ramírez J; Fernández-Sueiro JL; López-Mejías R; Montilla C; Arias M; Moll C; Alsina M; Sanmarti R; Lozano F; Cañete JD
J Rheumatol; 2012 May; 39(5):1035-41. PubMed ID: 22467926
[TBL] [Abstract][Full Text] [Related]
16. Correlations of FCGR2A 131R/H and FCGR3A 158V/F Polymorphisms with the Susceptibility of Peri-implantitis in Chinese Han Population.
Li P; Chen B; Zhao L; Yang F; Zhang Z; Cao Y; Hu Y
Mol Biotechnol; 2024 May; ():. PubMed ID: 38771420
[TBL] [Abstract][Full Text] [Related]
17. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.
Zhang W; Gordon M; Schultheis AM; Yang DY; Nagashima F; Azuma M; Chang HM; Borucka E; Lurje G; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
J Clin Oncol; 2007 Aug; 25(24):3712-8. PubMed ID: 17704420
[TBL] [Abstract][Full Text] [Related]
18. Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients.
Mahmoud I; Moalla M; Ben Tekaya A; Bouden S; Rouached L; Tekaya R; Saidane O; Gorji Y; Elleuch M; Laatar A; Hamdi W; Abdelmoula L; Sfar I
Drug Metab Pers Ther; 2023 Jun; 38(2):155-162. PubMed ID: 36919284
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in low-to-medium-affinity Fcγ receptors and autoimmune neutropenia in early childhood in a Danish cohort.
Kløve-Mogensen K; Steffensen R; Masmas TN; Glenthøj A; Jensen CF; Haunstrup TM; Ratcliffe P; Höglund P; Hasle H; Nielsen KR
Int J Immunogenet; 2023 Apr; 50(2):65-74. PubMed ID: 36754570
[TBL] [Abstract][Full Text] [Related]
20. Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer.
Shepshelovich D; Townsend AR; Espin-Garcia O; Latifovic L; O'Callaghan CJ; Jonker DJ; Tu D; Chen E; Morgen E; Price TJ; Shapiro J; Siu LL; Kubo M; Dobrovic A; Ratain MJ; Xu W; Mushiroda T; Liu G
Cancer Med; 2018 Nov; 7(11):5478-5487. PubMed ID: 30318772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
